Streetbeat News

Stock Prices

NIR

Trading in shares of Near Intelligence (NIR) has been halted pending the release of significant news from the company. Investors are awaiting further details to understand the implications of the announcement.

Portfolio Pulse from Benzinga Newsdesk

December 08, 2023 | 8:25 pm

AX

Axos Financial has completed the acquisition of two performing commercial real estate loan portfolios from the Federal Deposit Insurance Corporation, leading to an increase in its stock price.

Portfolio Pulse from Benzinga Newsdesk

December 08, 2023 | 8:18 pm

STWD

Starwood Prop Trust Inc. (NYSE:STWD) stock price is currently $20.14, experiencing a slight drop of 0.10%. Over the past month, STWD's stock has increased by 5.45%, and over the past year, it has seen a marginal rise of 0.02%. The company's P/E ratio of 15.63 is lower than the Mortgage REITs industry average of 85.02, which could suggest that the stock is undervalued or that shareholders have low growth expectations.

Portfolio Pulse from Benzinga Insights

December 08, 2023 | 8:15 pm

PLNHF

Planet 13 Holdings Inc. (OTC:PLNHF) has opened a new 4,000 sq. ft. cannabis dispensary in Waukegan, Illinois, as part of its retail expansion strategy. The store is designed to provide an immersive retail experience similar to the company's Las Vegas SuperStore. Located near a shopping and entertainment district, the dispensary is expected to attract customers from Chicago and Milwaukee. Planet 13 is also expanding in Florida with the acquisition of VidaCann, which will bring its total number of dispensaries in the state to 30. Despite these developments, PLNHF's stock was down 8.83% at $0.784 per share on Friday afternoon.

Portfolio Pulse from Joana Scopel

December 08, 2023 | 8:11 pm

TPIC

Over the past 3 months, 4 Wall Street analysts have provided ratings for TPI Composites (NASDAQ:TPIC), with an average price target of $4.75, which is a significant upside from the current price of $2.35. The consensus among these analysts is largely indifferent, with 3 indifferent ratings and 1 somewhat bullish rating. The current average price target represents a 36.67% decrease from the previous target of $7.50. Analysts' ratings are based on company data, financial statements, and insider information.

Portfolio Pulse from Benzinga Insights

December 08, 2023 | 8:01 pm

TSN

Over the past 15 years, Tyson Foods (NYSE:TSN) has produced an average annual return of 14.32%, outperforming the market. A $1000 investment in TSN 15 years ago would be worth $7,232.77 today. The company currently has a market cap of $18.27 billion. The article highlights the impact of compounded returns on investment growth over time.

Portfolio Pulse from Benzinga Insights

December 08, 2023 | 8:01 pm

MOH

Molina Healthcare (NYSE:MOH) has delivered an average annual return of 21.77% over the past 5 years, outperforming the market by 10.03% annually. A $100 investment in MOH 5 years ago would be worth $272.91 today. The company's market capitalization stands at $21.19 billion.

Portfolio Pulse from Benzinga Insights

December 08, 2023 | 8:01 pm

AAPL

Tang Tan, Apple Inc.'s vice president of product design for the iPhone and smartwatch, is set to leave the company in February. This departure is expected to lead to a reorganization within the hardware engineering group. Tan's exit is not yet public and was reported by sources familiar with the matter.

Portfolio Pulse from Benzinga Newsdesk

December 08, 2023 | 8:00 pm

CMTL

CURV

CYN

HCP

INTS

MBI

U.S. stocks saw gains with the Dow Jones rising over 100 points. Energy shares led the gains, while real estate lagged. Intensity Therapeutics' shares surged 83% after presenting positive data, MBIA spiked 77% following an extraordinary dividend announcement, and Torrid Holdings climbed 21% on strong financial results. Conversely, Cyngn, HashiCorp, and Comtech Telecommunications saw significant drops after negative announcements. Oil prices increased, gold declined, and the U.S. non-farm payrolls and unemployment rate showed positive signs.

Portfolio Pulse from Avi Kapoor

December 08, 2023 | 7:59 pm

BLUE

Bluebird Bio's stock is trading lower following the FDA's decision to add a black box warning to its gene therapy product, Lyfgenia, due to the risk of hematologic malignancy.

Portfolio Pulse from Benzinga Newsdesk

December 08, 2023 | 7:55 pm